AstraZeneca buys Almirall lung drugs for up to $2.1 billion
July 30, 2014 at 04:13 AM EDT
LONDON (Reuters) - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's lung drugs.
